Patent directory · USPTO A61K / A61P
Patents matching “United Kingdom Research and Innovation”
23 pharma patents match "United Kingdom Research and Innovation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 23 pharmaceutical patents matching "United Kingdom Research and Innovation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12286657
Methods and compositions
granted -
US 12268749
Cell-penetrating peptides
granted -
US 11980637
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
granted -
US 11833171
Materials and methods relating to stabilised polymeric silicate compositions
granted -
US 11684572
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
granted -
US 11567073
Receptor tyrosine kinase biomarkers
granted -
US 11369697
Liposome nanoparticles for tumor magnetic resonance imaging
granted -
US 11364211
Methods for selecting phosphatase selective and non-selective phosphatase inhibitors
granted -
US 11337941
Inhibitors and their uses
granted -
US 11331286
Inhibitors and their uses
granted -
US 11154519
Inhibitors and their uses
granted -
US 11007217
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
granted -
US 11000502
Antimicrobial compositions comprising copper-hydroxypyrone complexes
granted -
US 10954198
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted -
US 10898511
Materials and methods relating to stabilised polymeric silicate compositions
granted -
US 10882895
Nucleic acid encoding angiopoietin-2 specific Tie2 receptor
granted -
US 10722459
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
granted -
US 10596227
Polypeptide targeting to mitochondria
granted -
US 10526297
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted -
US 10421805
Anti-hepatitis C antibodies and antigen binding fragments thereof
granted -
US 10208100
Angiopoietin-2 specific TIE2 receptor
granted -
US 10201499
Nanoparticle formulation
granted -
US 10100020
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted